These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3423424)

  • 21. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
    O'Leary TD; Sansom LN
    J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipyrine disposition in relation to lowered anticonvulsant plasma level during pregnancy.
    Chiba K; Ishizaki T; Tabuchi T; Wagatsuma T; Nakazawa Y
    Obstet Gynecol; 1982 Nov; 60(5):620-6. PubMed ID: 6815599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
    Kearns CM; Blakley RL; Santana VM; Crom WR
    Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenytoin-misonidazole: possible metabolic interaction.
    Gangji D; Schwade JG; Strong JM
    Cancer Treat Rep; 1980 Jan; 64(1):155-6. PubMed ID: 7379050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
    Madden T; de Lima M; Thapar N; Nguyen J; Roberson S; Couriel D; Pierre B; Shpall EJ; Jones RB; Champlin RE; Andersson BS
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):56-64. PubMed ID: 17222753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting antiepileptic drug pharmacokinetics in community-dwelling elderly.
    Cloyd JC; Marino S; Birnbaum AK
    Int Rev Neurobiol; 2007; 81():201-10. PubMed ID: 17433925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of epsilon-aminocaproic acid in horses.
    Ross J; Dallap BL; Dolente BA; Sweeney RW
    Am J Vet Res; 2007 Sep; 68(9):1016-21. PubMed ID: 17764418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of phenytoin elimination by multiple-dose activated charcoal.
    Mauro LS; Mauro VF; Brown DL; Somani P
    Ann Emerg Med; 1987 Oct; 16(10):1132-5. PubMed ID: 3662159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased phenytoin metabolism in rabbits after phenytoin pretreatment.
    Wilensky AJ; Lowden JA
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):365-8. PubMed ID: 981792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of phenytoin on the clinical pharmacokinetics of amiodarone.
    Nolan PE; Marcus FI; Karol MD; Hoyer GL; Gear K
    J Clin Pharmacol; 1990 Dec; 30(12):1112-9. PubMed ID: 2273084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Intralipid infusion on the elimination of phenytoin.
    Straathof DJ; Driessen O; Meijer JW; Van Rees H; Vermeij P; Vermeij TA
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):180-6. PubMed ID: 6712353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenytoin auto-induction? Case reports.
    Miller R; Bill PL; Du Toit J
    S Afr Med J; 1989 Apr; 75(7):332-3. PubMed ID: 2928882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of propylene glycol in the rabbit.
    Yu DK; Sawchuk RJ
    J Pharmacokinet Biopharm; 1987 Oct; 15(5):453-71. PubMed ID: 3694492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The excretion of 5,5-diphenylhydantoin in the semen of man and the rabbit comparison with plasma concentrations of the drug.
    Leger RM; Swanson BN; Gerber N
    Proc West Pharmacol Soc; 1977; 20():69-72. PubMed ID: 896862
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacokinetics of tetrachloroethylene in steady stage conditions].
    Müller C; Fleischer C; Fahnert R
    Z Gesamte Hyg; 1989 Dec; 35(12):706-9. PubMed ID: 2631462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New pharmacokinetic methods: I. Estimation of mean serum concentration from trough serum concentration.
    Browne TR; Greenblatt DJ; Szabo GK; Evans JE; Evans BA
    J Clin Pharmacol; 1990 Jun; 30(6):482-8. PubMed ID: 2355100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man.
    Svendsen TL; Kristensen MB; Hansen JM; Skovsted L
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):439-41. PubMed ID: 971708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is phenytoin metabolism dose-dependent by enzyme saturation or by feedback inhibition?
    Perucca E; Makki K; Richens A
    Clin Pharmacol Ther; 1978 Jul; 24(1):46-51. PubMed ID: 657718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting phenytoin serum concentrations.
    Koren G
    Neurology; 1983 Sep; 33(9):1251-2. PubMed ID: 6684271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.